Ibrahim Nassour, MD, MSCS - Research

Research at a glance

Top areas of exploration

Pancreatic Neoplasms , 23 publications
Adenocarcinoma , 17 publications
Robotic Surgical Procedures , 12 publications
Pancreaticoduodenectomy , 12 publications

Research activity

92 publications

1,539 citations

Why is this important?

Active clinical trials

Testing the Use of the Usual Chemotherapy Before and After Surgery for Removable Pancreatic Cancer

This phase III trial compares perioperative chemotherapy (given before and after surgery) versus adjuvant chemotherapy (given after surgery) for the treatment of pancreatic cancer that can be removed by surgery (removable/resectable). Chemotherapy鈥�

Investigator: Ibrahim Nassour
Status: Accepting Candidates
Ages: 18 Years - N/A
Sexes: All

My publications

92 publications

2021

Minimally Invasive Techniques for Pancreatic Resection.

Surgical oncology clinics of North America

鈥�

2021

National Trends in Robotic Pancreas Surgery.

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract

鈥�

2021

Neoadjuvant Chemotherapy for Pancreatic Adenocarcinoma Lessens the Deleterious Effect of Omission of Adjuvant Chemotherapy.

Annals of surgical oncology

鈥�

2021

Neoadjuvant therapy versus upfront surgery for early鈥恠tage left鈥恠ided pancreatic adenocarcinoma: A propensity鈥恗atched analysis from a national cohort of distal pancreatectomies

Journal of Surgical Oncology

2021

Omission of Right Hemicolectomy May be Safe for Some Appendiceal Goblet Cell Adenocarcinomas: A Survival Analysis of the National Cancer Database.

Annals of surgical oncology

鈥�

网红黑料